that are not yet available for restoring a patient’s normal abilities to receive and process sensory input as part of post-cancer treatment, in particular.
“Chemotherapy undoubtedly negatively influences the peripheral nervous system, which is often viewed as the main culprit of neurologic disorders during cancer treatment. This occurs through synaptic communication between neurons. Through an elegant series of studies, we show that those hubs of communication in the central nervous system are also vulnerable to cancer treatment’s adverse effects,” says Stephen N. (Nick) Housley, a postdoctoral researcher in the School of Biological Sciences, the Integrated Cancer Research Center, and the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech, and is the study’s lead author.
The study thereby states that sensorimotor disability occurring because of cancer treatment is due to the joint expression of independent defects that occurs in both peripheral and central elements of sensorimotor circuits.